Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of dual atrioventricular nodal physiology in dual atrioventricular nodal non-reentrant tachycardia via adenosine triphosphate injection during atrial pacing: A novel insight into the role of leftward inferior extension.
Arai H, Asakawa T, Sagawa Y, Yasui Y, Oda A, Murata K, Nakagawa K, Sasano T, Aonuma K, Yamauchi Y. Arai H, et al. Among authors: nakagawa k. J Cardiovasc Electrophysiol. 2024 Mar;35(3):505-510. doi: 10.1111/jce.16172. Epub 2024 Jan 4. J Cardiovasc Electrophysiol. 2024. PMID: 38178380
Anatomical approach to suppression of para-Hisian ventricular arrhythmias with changes in QRS morphology following ablation at the earliest activation site.
Sagawa Y, Asakawa T, Shigeta T, Murata K, Arai H, Oda A, Kurabayashi M, Miyamoto K, Takitsume A, Yoshinaga M, Nakagawa K, Ishihara S, Okishige K, Sasano T, Yamauchi Y. Sagawa Y, et al. Among authors: nakagawa k. Heart Rhythm. 2024 May 24:S1547-5271(24)02630-4. doi: 10.1016/j.hrthm.2024.05.036. Online ahead of print. Heart Rhythm. 2024. PMID: 38797309
Reply to letter to the editor by Li et al.
Ohyama S, Aoki Y, Inoue M, Nakajima T, Sato Y, Sato M, Yoh S, Takahashi H, Nakajima A, Eguchi Y, Orita S, Inage K, Shiga Y, Nakagawa K, Ohtori S. Ohyama S, et al. Among authors: nakagawa k. J Orthop Sci. 2024 Jun 19:S0949-2658(24)00094-0. doi: 10.1016/j.jos.2024.05.002. Online ahead of print. J Orthop Sci. 2024. PMID: 38902163 No abstract available.
Corrigendum to "A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKI and platinum-based chemotherapy" [Lung Cancer 177 (2023) 44-50].
Takeda M, Shimokawa M, Nakamura A, Nosaki K, Watanabe Y, Kato T, Hayakawa D, Tanaka H, Takahashi T, Oki M, Tachihara M, Fujimoto D, Hayashi H, Yamaguchi K, Yamamoto S, Iwama E, Azuma K, Hasegawa K, Yamamoto N, Nakagawa K. Takeda M, et al. Among authors: nakagawa k. Lung Cancer. 2024 Jun 17:107852. doi: 10.1016/j.lungcan.2024.107852. Online ahead of print. Lung Cancer. 2024. PMID: 38890056 No abstract available.
4,721 results